Evidence map›Paper›PMID 21467165›Full record

ArticleCancer research2011

Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.

Maya Zigler, Gabriel J Villares, Andrey S Dobroff, Hua Wang, Li Huang, Russell R Braeuer, Takafumi Kamiya, Vladislava O Melnikova, Renduo Song, Ran Friedman and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Tumor Microenvironment in Melanoma Brain Metastasis: A New Potential Target?International journal of molecular sciences · 2025
    Review
  3. Article
  4. ATF-3 expression inhibits melanoma growth by downregulating ERK and AKT pathways.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  5. [The role of CD146 in mesenchymal stem cells].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. MCAM expression is associated with poor prognosis in non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Maya ZiglerDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Gabriel J Villares
Andrey S Dobroff
Hua Wang
Li Huang
Russell R Braeuer
Takafumi Kamiya
Vladislava O Melnikova
Renduo Song
Ran Friedman
Rhoda M Alani
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center · USBoston Medical Center · USBoston University · US

Funding

TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMAR01CA076098 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BARELI, MENASHE · 1999 to 2012
$3.1M
NCI NIH HHS CA76098NCI NIH HHS R01 CA076098
6 · The paper itself

Abstract

The acquisition of the metastatic melanoma phenotype is associated with increased expression of the melanoma cell adhesion molecule MCAM/MUC18 (CD146). However, the mechanism by which MUC18 contributes to melanoma metastasis remains unclear. Herein, we stably silenced MUC18 expression in two metastatic melanoma cell lines, A375SM and C8161, and conducted cDNA microarray analysis. We identified and validated that the transcriptional regulator, inhibitor of DNA binding-1 (Id-1), previously shown to function as an oncogene in several malignancies, including melanoma, was downregulated by 5.6-fold following MUC18 silencing. Additionally, we found that MUC18 regulated Id-1 expression at the transcriptional level via ATF-3, which itself was upregulated by 6.9-fold in our cDNA microarray analysis. ChIP analysis showed increased binding of ATF-3 to the Id-1 promoter after MUC18 silencing. To complement these studies, we rescued the expression of MUC18, which reversed the expression patterns of Id-1 and ATF-3. Moreover, we showed that MUC18 promotes melanoma invasion through Id-1, as overexpression of Id-1 in MUC18-silenced cells resulted in increased MMP-2 expression and activity. To our knowledge, this is the first demonstration that MUC18 is involved in cell signaling regulating the expression of Id-1 and ATF-3, thus contributing to melanoma metastasis.

Indexed as

Gene Expression Regulation, NeoplasticActivating Transcription Factor 3AnimalsCD146 AntigenCell Line, TumorChromatin ImmunoprecipitationDisease ProgressionFemaleHumansInhibitor of Differentiation Protein 1MelanomaMiceMice, Inbred BALB CNeoplasm MetastasisNeoplasm TransplantationActivating Transcription Factor 3ATF3 protein, humanAtf3 protein, mouseCD146 AntigenID1 protein, humanIdb1 protein, mouseInhibitor of Differentiation Protein 1

Identifiers

PMID21467165
PMCPMC3096710
OpenAlexW2049954943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.